Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Urology Physician in Jacksonville, FL
NPI: 1558314484Primary Practice Location
SHANDS JACKSONVILLE
655 W 8th St, Jacksonville, FL
Primary Employer
University of Florida Jacksonville Physicians, Inc.
ufhealthjax.org
HQ Phone
Get MBBS Kethandapatti's Phone Numberphone_androidMobile
Get MBBS Kethandapatti's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
FL State Medical License
FL State Medical License
2018 - 2026
NC State Medical License
2010 - 2019
MA State Medical License
1995 - 2011
IL State Medical License
1999 - 2002
American Board of Urology
Urology
Memorial Sloan Kettering Cancer Center
Fellowship • Urological Oncology
1997 - 1999
UMass Chan Medical School
umassmed.edu
Residency • Urology
1993 - 1997
BronxCare Health System
Internship • Transitional Year
1992 - 1993
British Hospitals
Surgery
1986 - 1992
Madras Medical College
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 85 | 133 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 36 | 47 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 13 |
Authors: Harold Tsai
Journal: J Urol
Authors: Cheng Du
Publication Date: 2012-04-12
Lead Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Cytology Specimen Collection Procedure
Lead Sponsor: enGene, Inc.
Intervention / Treatment: DRUG: EG-70 (phase 2), DRUG: EG-70 (phase 1)
Lead Sponsor: Prostate Cancer Clinical Trials Consortium
Intervention / Treatment: OTHER: Standard of Care
